Fen Phen Health

shortness of breath

chest pain

primary pulmonary hypertension

a heart murmur

finger, foot, ankle, and leg swelling





Fen-Phen History

Phentermine and pondimin combined in a low dose was found in a 1984 study to help suppress appetite for the purpose of weight loss. The combination of two drugs appeared to have fewer side effects then when the drugs were taken individually. Fen-phen became the name of the combined drugs and it immediately took off in popularity. A study in 1992 found 120 obese patients that were treated with fen-phen lost an average of 30 pounds. The two drugs pondimin and redux, both manufactured by American Home Products, were initially approved for short-term use. Redux was approved in the U.S. in 1995 and it was an immediate success.

Fen-phen’s miracle status came to a halting end when the Mayo Clinic released a study finding fen-phen to cause very serious side effects and health complications in 1997. The most frequent complication was heart valve defects, more specifically the aortic and mitral valves. Blood became regurgitated into the ventricle and into the left atrium. In July of 1997 the FDA issued a warning regarding the heart valve problems linked to the use of fen-phen, specifically redux and pondimin. The FDA then withdrew fenfluramine and redux from the U.S. market one month later and recommended anyone who used fen-phen to see a medical examination to ensure their safety.

Fen-phen is in the midst of numerous class-action lawsuits for the drug company’s failure to disclose information that could have prevented the health risks and complications of hundreds and possibly thousands of patients. Many fen-phen takers have found that their health has had further deterioration due to their use of the diet drug over time. Our fen-phen lawyers can provide the highest level of legal expertise to ensure that the proper compensation is received. If you have any questions regarding your legal rights, please contact us, and a phen-fen lawyer can discuss your case with you.

Top of Page

Fen-Phen Medical Issues
Valvular Heart Disease- The injury frequently associated with the use of pondimin or redux. The two drugs cause the valves in the heart to allow blood flow backwards through them.

Primary Pulmonary Hypertension (PPH)- PPH is a disease that result in increased pulmonary artery pressure that is caused by pondimin or redux and is the most dangerous and deadly effect of fen-phen.

Endocardial Fibrosis- This injury is diagnosed by fibrosis and restrictive cardiomyopathy.

Home Legal Issues Health Complications About Primary Pulmonary Hypertension Contact Us Fen-Phen History Frequently Asked Questions